Clinical Trial Details

Trial ID: L0836
Source ID: IRCT2015120925447N1
Associated Drug: Zaharia
Title: The effect of Zataria multiflora Boiss in the treatment of non alcoholic fatty liver disease
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non alcoholic fatty liver. <br>Non alcoholic fatty liver disease;K 76.0;Non alcoholic fatty liver disease
Interventions: Intervention 1: Intervention group : 700 mg (two 350 mg cap ) Shirazi thyme powder bid for 90 days. Intervention 2: Control group : 700 mg (two cap 350 mg ) wheat powder bid for 90 days.;Treatment - Drugs;Placebo;Intervention group : 700 mg (two 350 mg ca
Outcome Measures: Alaninaminotransferase. Timepoint: Before intervention and three months after intervention. Method of measurement: Blood sampling.;Grade of fatty liver. Timepoint: Before intervention and three months after intervention. Method of measurement: Ultrasonography.Blood pressure. Timepoint: Before intervention and three months after intervention. Method of measurement: By manometer according to mmHg.;Fasting blood sugar. Timepoint: Before intervention and three months after intervention. Method of measurement: Blood sampling.;Aspartateaminotransferase. Timepoint: Before intervention and three months after intervention. Method of measurement: Blood sampling.;Body mass index. Timepoint: Before intervention and three months after intervention. Method of measurement: Scale and measuring tape.;Waist circumference. Timepoint: Before intervention and three months after intervention. Method of measurement: By measuring tape.;Hip circumference. Timepoint: Before intervention and three months after intervention. Method of measurement: By measuring tape.;Insulin. Timepoint: Before intervention and three months after intervention. Method of measurement: Blood sampling.;Lipid profile. Timepoint: Before intervention and three months after intervention. Method of measurement: Blood sampling.
Sponsor/Collaborators: Vice chancellor for research, Shiraz University of Medical Sciences
Gender: All
Age: 20 years65 years
Phases: Not applicable
Enrollment: 90
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 16/10/2016
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of);Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/21282